Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Involvement of STAT5 in Oncogenesis
Clarissa Esmeralda Halim, Shuo Deng, Mei Shan Ong, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 316-316
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
Sareshma Sudhesh Dev, Syafiq Asnawi Zainal Abidin, Reyhaneh Farghadani, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 95
Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
Raghuveer Kavarthapu, Rajakumar Anbazhagan, Maria Dufau
Cancers (2021) Vol. 13, Iss. 18, pp. 4685-4685
Open Access | Times Cited: 66
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Grace L. Wong, Sara G. Manore, Daniel Doheny, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 84-106
Open Access | Times Cited: 64
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
Cassandra A. Hathaway, Megan S. Rice, Laura C. Collins, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 27
The role of prolactin in central nervous system inflammation
Edgar Ramos-Martínez, Iván Ramos-Martínez, Gladys Molina-Salinas, et al.
Reviews in the Neurosciences (2021) Vol. 32, Iss. 3, pp. 323-340
Open Access | Times Cited: 44
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1387-1387
Open Access | Times Cited: 7
The potential role of targeting the leptin receptor as a treatment for breast cancer in the context of hyperleptinemia: a literature review
Abbas S. Neamah, Al-Hassan Soliman Wadan, Fadhel M. Lafta, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 6
Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer
Julia Arebro, Rebecca Towle, Che-Min Lee, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Cellular mechanisms mediating the anti-cancer effects of carnosol on gingiva carcinoma
Nassima Gassib, Hawraa Issa, Lionel Loubaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness
Raghuveer Kavarthapu, Maria Dufau
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 21
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression
Ashlie Munoz, Ryan Urak, Ellie Taus, et al.
Molecular Therapy (2023) Vol. 32, Iss. 2, pp. 527-539
Open Access | Times Cited: 11
Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity
Xu Jiang, Jiaqi Wang, Liangyu Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
ECM Signatures Reveal Quiescent Stem Cell Diversity in the Colonic Niche
Séamus Hickey, Massimo Andreatta, Christina Enright, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
DLAT is involved in ovarian cancer progression by modulating lipid metabolism through the JAK2/STAT5A/SREBP1 signaling pathway
Hui Wang, Shen Luo, Yue Yin, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer
Karolina Jabłońska, Alicja Kmiecik, Katarzyna Nowińska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1416-1416
Open Access
Pubertal low dose exposure to benzophenone-3 (BP-3) alters murine mammary stem cell functions
Hui Gao, Xintong Yang, Pengge Pan, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117982-117982
Open Access
Prognostic and clinicopathological roles of circular RNA expression in chemoresistance in head and neck squamous cell carcinoma: a systematic review
Sayan Kumar Das, Sameer Khasbage, Abhishek Mishra, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Tumor Cell‐Expressed Herpesvirus Entry Mediator Regulates Proliferation and Adaptive Immunity in Ovarian Cancer
Yun Lu, Yijun Zhang, Wenxuan Li, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 3
Open Access
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia
Annika Dechow, Sanna Timonen, Aleksandr Ianevski, et al.
Leukemia (2025)
Open Access
Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with Candida albicans Infection
Yi‐Ping Hsieh, Yu‐Hsueh Wu, Siao Muk Cheng, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4833-4833
Open Access | Times Cited: 18
The JAK-STAT Signaling Pathway in Epilepsy
Huaiyu Sun, Di Ma, Yu Cheng, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 10, pp. 2049-2069
Closed Access | Times Cited: 18
Intrinsic RIG-I restrains STAT5 activation to modulate anti-tumor activity of CD8+ T cells
Xinyi Jiang, Jian Lin, Chengfang Shangguan, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 9
Open Access | Times Cited: 10
Optimizing therapeutic targets for breast cancer using boolean network models
Domenico Sgariglia, Flávia Raquel Gonçalves Carneiro, Luis Alfredo Vidal de Carvalho, et al.
Computational Biology and Chemistry (2024) Vol. 109, pp. 108022-108022
Open Access | Times Cited: 3
STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC
Yan Li, Fanjing Jiang, Suhua Zhu, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 3
Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid Tumors
Cole D. Davidson, Noelle E. Gillis, Frances E. Carr
Cancers (2021) Vol. 13, Iss. 17, pp. 4254-4254
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top